Honoree: Nabil Dib, Medical Director
Nabil Dib, MD, M.SC., FACC
Director, Cardiovascular Research
Mercy Gilbert Medical Center
A highly respected interventional cardiologist, Dr. Nabil Dib, director of cardiovascular research for Chandler Regional and Mercy Gilbert Medical centers, serves as principal investigator for a variety of cardiovascular clinical trials, including cardiac regeneration involving cell and gene transplant, new pharmaceuticals and genomics.
With a support team of 10, Dib treats patients with advanced cardiac disease and provides expert consultation to referring physicians from all specialties. His clinical services include assessment and diagnosis of cardiac diseases, angina, heart failure, arrhythmias, and vascular disorders, as well as pre-operative cardiac surgical evaluations.
In addition, Dib performs more than 330 non-surgical procedures annually, such as cardiac catheterization, balloon angioplasty, coronary artery stenting, intravascular ultrasound, percutaneous left ventricular assist devices, and peripheral vascular interventions.
A tireless scientist, Dib is committed to improving the lives of people suffering from heart disease by developing innovative treatment methods. One of his current areas of focus involves cardiac adult stem cell transplantation to determine if heart tissue damaged by a heart attack can, in fact, be regenerated. His research is also exploring the regeneration of blood vessels through gene therapy. To date, he has completed two leading-edge research projects in translational adult stem cell research, which led to FDA clearance for both projects to begin Phase I clinical trials.
Dib is the founding member and president of the International Society for Cardiovascular Translational Research, a nonprofit organization whose purpose is to bring innovations tested and proven through research into mainstream medical practice for the benefit of patients.
[stextbox id="grey" image="www.chw.edu"]www.chw.edu[/stextbox]
Finalist: Mitchell Shub, MD
Mitchell Shub, MD
Phoenix Children’s Hospital
Dr. Mitchell Shub, medical director of research at Phoenix Children’s Medical Group, has been in a leadership position at the hospital for 25 years. While he still sees patients on a daily basis, most of his time is spent overseeing research operations on campus.
Additionally, he is co-chair of the Institutional Review Board, and chair of the Scientific Review Committee that reviews all investigator-initiated research studies and fosters collaborations with the University of Arizona Medical School, Arizona State University, T-Gen and Mayo Clinic.
Shub is involved in three research projects of his own and is developing two others, funded by grants from the National Institute of Health, UA and pharmaceutical companies.
In the health care industry for 28 years, Shub serves as professor of clinical pediatrics/associate head of the department of pediatrics at the UA. In this capacity, he oversees all pediatric training for medical students, and with the dean makes decisions on appointments, academic promotions and academic program development.
[stextbox id="grey" image="www.phoenixchildrens.com"]www.phoenixchildrens.com[/stextbox]
David Winston, MD, FACP, AGAF
Director, Gastroenterology & Hepatology
Cigna Medical Group
Dr. David Winston has a long-standing commitment to medical research, and throughout his 35 years in medicine he has worked to develop a deeper understanding of the treatment and prevention of colon cancer and Hepatitis C. Winston has been director of gastroenterology and hepatology at Cigna Medial Group in Sun City for nearly 20 years, and is a clinical investigator for the University of Arizona College of Medicine.
He has participated in 33 research studies, 18 of which he served as principal investigator. He has published 33 papers and lectured in 25 cities and five countries around the world about new advancements in GI treatment and research.
As a practicing physician, Winston treats patients daily for a wide variety of gastro and digestive needs, such as stomach pain, frequent indigestion, and chronic GI problems, and encourages patients to participate in clinical trials so science can progress in the areas of early cancer detection.
[stextbox id="grey" image="www.cigna.com"]www.cigna.com[/stextbox]